|
|
|
|
|
|
News and Articles on Geron Corporation (GERN)
Reality Check: The Inevitable Disappointments from Stem Cells May 28, 2009
The day after Barack Obama was inaugurated as president in January, the U.S. Food and Drug Administration green-lighted an application from Geron Corporation to pursue the first phase I clinical trial of an ESC-based therapy (in this case, for spinal cord injury). President Obama, who ran on a pro-ESC research platform, cannot take credit for that regulatory first, which was largely a coincidence of timing. (Scientific American)
Inside The Obama Notre Dame Controversy May 16, 2009
January 23, 2009 -The U.S. Food and Drug Administration (FDA) gave the go-ahead for Geron Corporation to start a phase I safety trial of its therapy GRNOPC1 for spinal cord injuries, the Menlo Park, Calif. based company announced today. (CBS News)
Perry criticizes Washington on abortion Feb 25, 2009
Perry also attacked embryonic stem cell research and a January FDA ruling allowing the first clinical trials using embryonic stem cells on people with spinal injuries at Geron Corporation in Minnesota, calling it another sign of Washington s misplaced priorities. I am deeply disturbed that any experiment that uses the tissue of unborn children as raw material, particularly obtained from a life ended prematurely, is going to have a terrible impact upon this state, he said. (KHOU.com, TX)
[ Terms Of Use | Privacy | About ]
©1998-2006 SurfWax, Inc.
All rights reserved. Patents pending.
|
|
|
Copyright SurfWax, Inc. 2006
|
|
